New grad roles at Celea Therapeutics
Celea Therapeutics is a clinical-stage biopharmaceutical company developing next-generation treatments for serious respiratory diseases. Its lead program, deupirfenidone, is in Phase 3 development for idiopathic pulmonary fibrosis and other fibrotic lung diseases.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 11–50 employees
- Open roles
- 4
No current roles
Clear a filter to see every role.
Get new Celea Therapeutics new grad roles by email
Free account. Get new Celea Therapeutics new grad roles by email or push the minute they post.
